Overview
The following procedure is for simultaneous transfection and plating of
RAW 264.7 cells. This protocol results in approximately 50% to 70% cell viability,
and of those viable cells, 20% to 40% are transfected when using pEYFP-N1
from Clontech.
Details
Details of this protocol, Transfecting And Plating RAW 264.7 Cells With Lipofectamine 2000, are located on a web site other than Biocompare Protocols.